48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion.
D000328:Adult; D003250:Constriction; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D011725:Pyridines / Q000494:pharmacology*; D013844:Thiazoles / Q000494:pharmacology*; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D014680:Veins / Q000502:physiology
D010972:Platelet Activating Factor; D011725:Pyridines; D013844:Thiazoles; C052520:3-(3-pyridinyl)-1H,3H-pyrrolo(1,2-c)thiazole-7-carboxamide; D010959:Tissue Plasminogen Activator